Eye Care
Aalto University team reports laser approach that may slow dry macular degeneration
Ti AI ṣe iroyin Àwòrán tí AI ṣe Ti ṣayẹwo fun ododo
Researchers in Finland say a temperature‑controlled, near‑infrared laser can trigger the eye’s repair responses and could slow early dry age‑related macular degeneration; animal data support human safety trials planned for spring 2026.
Scientists at the University of Southern California are starting a phase 2b clinical trial to test a microscopic stem cell implant aimed at restoring vision in patients with advanced dry age-related macular degeneration. The hair-thin patch seeks to replace damaged retinal cells, building on earlier research that showed safety and vision gains in some participants. Researchers hope it could offer a way to reverse vision loss where current treatments fall short.
Ti AI ṣe iroyin Ti ṣayẹwo fun ododo
A pioneering clinical trial at the University of Michigan has demonstrated that adult stem cell transplants can safely improve vision in patients with advanced dry age-related macular degeneration. Early results from six participants show significant sight gains without serious side effects. Researchers are now evaluating higher doses in additional patients.